Apolipoproteins J and E co-localise with amyloid in gelatinous drop-like and lattice type I corneal dystrophies

British Journal of Ophthalmology

Volumn 83, Issue 10, 1999, Pages 1178-1182

  Nishida, Kohji ^a   Quantock, Andrew J ^a,c   Dota, Atsuyoshi ^a   Choi Miura, Nam Ho ^b   Kinoshita, Shigeru ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; ANTIBODY; APOLIPOPROTEIN E; CLUSTERIN; CONGO RED; IMMUNOGLOBULIN G ANTIBODY;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA DYSTROPHY; CORNEA EPITHELIUM; CORNEA STROMA; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENILE PLAQUE;

EID: 0032836944     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.83.10.1178     Document Type: Article

References (38)

1. Li S, Edward DP, Ratnaker KS, et al. Clinicohistopathological findings of gelatinous drop-like corneal dystrophy among Asians. Cornea 1996;15:355-62.
2. Nakaizumi G. A rare case of corneal dystrophy. Nippon Ganka Gakkai Zasshi 1914;18:949-50.
3. Kivelä T, Tarkkanen, McLean I, et al. Immunohistochemical analysis of lattice corneal dystrophies types I and II. Br J Qphthalmol 1993;77:799-804.
4. Stone EM, Mathers WD, Rosenwasser GOD, et al. Three autosomal dominant corneal dystrophies map to chromosome 5q. Nat Genet 1994;6:47-52.
5. Gregory CY, Evans K, Bhattacharya S. Genetic refinement of the chromosome 5 lattice corneal dystrophy type I locus to within a 2cM interval. J Med Genet 1995;32:224-6.
6. Munier FL, Korvatska E, Djemai A, et al. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 1997;15:247-51.
7. Korvatska E, Munier FL, Djemai A, et al. Mutation hot spots in 5q31-linked corneal dystrophies. Am J Hum Genet 1998;62:320-4.
8. Gupta S, Hodge WG, Damji KF, et al. Lattice corneal dystrophy type I in a Canadian kindred is associated with the Arg 124→Cys mutation in the kerato-epithelin gene. Am J Ophthalmol 1998;125:547-9.
9. Dota A, Nishida K, Honma Y, et al. Gelatinous drop-like corneal dystrophy is not one of the βig-h3-mutated corneal amyloidoses. Am J Ophthalmol 1998;126:832-3.
10. Tsujikawa M, Kurahashi H, Tanaka T, et al. Homozygosity mapping of a gene responsible for gelatinous drop-like corneal dystrophy to chromosome 1p. Am J Hum Genet 1998;63:1073-7.
11. Tsujikawa M, Kurahashi H, Tanaka T, et al. Identification of the gene responsible for gelatinous drop-like corneal dystrophy. Nat Genet 1999;21:420-3.
12. Wisniewski T, Golabek AA, Kida E, et al. Conformational mimicry in Alzheimer's disease. Role of apolipoproteins in amyloidogenesis. Am J Pathol 1995;147:238-44.
13. Harr SD, Uint L, Holloster R, et al. Brain expression of apolipoproteins E, J and A-I in Alzheimer's disease. J Neurochem 1996;66:2429-35.
14. Choi-Miura N-H, Ihara Y, Fukuchi K, et al. SP-40,40 is a constituent of Alzheimer's amyloid. Acta Neuropathol 1992;83:260-4.
15. Matsubara E, Frangione B, Ghiso J. Characterization of apolipoprotein J-Alzheimer's interaction. J Biol Chem 1995;31:7563-7.
16. Ghiso J, Matsubara E, Koudinov A, et al. The cerebrospinalfluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem J 1993;293:27-30.
17. Oda T, Wals P, Osterburg HH, et al. Clusterin (apoJ) alters the aggregation of amyloid b-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp Neurology 1995;136:22-31.
18. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to b-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-81.
19. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Binding of human apolipoprotein E to synthetic amyloid b peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci. USA 1993;90:8098-102.
20. Wisniewski TEM, Castano A, Gloabek T, et al. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol 1994;145:1030-5.
21. Nishida K, Kawasaki S, Adachi W, et al. Apolipoprotein J expression in human ocular surface epithelium. Invest Ophthalmol Vis Sci 1996;37:2285-92.
22. Murphy BF, Kirszbaum L, Waker ID, et al. SP-40,40, a newly identified normal human protein found in the SC5b-9 complex of complement and in the immune deposits in glomerulonephritis. J Clin Invest 1988;81;1858-64.
23. Choi N-H, Tobe T, Hara K, et al. Sandwich ELISA assay for quantitative measurement of SP-40.40 in seminal plasma and serum. J Immunol Meth 1990;131:159-63.
24. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterisation of a novel cerebro-vascular amyloid protein. Biochem Biophys Res Commun 1984;120:885-90.
25. Masters CL, Simms G, Weinman MA, et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 1985;82:4245-9.
26. Kang J, Lemaire H-G, Multhaup G, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:733-6.
27. Shoji M, Golde TE, Ghiso J, et al. Production of the Alzheimer amyloid b-peptide protein by normal proteolytic processing. Science 1992;58:126-9.
28. Hassen C, Schlossmacher MG, Hung AY, et al. Amyloid b-peptide is produced by cultured cells during normal metabolism. Nature 1992;359:322-5.
29. Dota A, Nishida K, Quantock AJ, et al. Clusterin in human corneal endothelium and aqueous humor. Exp Eye Res 1999;(in press).
30. Nishida K, Adachi W, Shimizu-Matsumoto A, et al. A gene expression profile of human corneal epithelium and the isolation of human keratin 12 cDNA. Invest Ophthalmol Vis Sci 1996;37:1800-9.
31. Reeder DJ, Stuart WD, Witte DP, et al. Local synthesis of apolipoprotein J in the eye. Exp Eye Res 1995;60:495-504.
32. Bales KR, Verina T, Dodel RC, et al. Lack of apolipoprotein E dramatically reduces amyloid B-peptide deposition. Nat Genet 1997;17:263-4.
33. Takacs L, Boross P, Tozser J, et al. Transforming growth factor-B induced protein, BIG-H3, is present in degraded form and altered localization in lattice corneal dystrophy type 1. Exp Eye Res 1998;66:739-45.
34. Kawasaki S, Nishida K, Quantock AJ, et al. Amyloid and Pro501Thr-mutated Big-h3 gene product co-localize in lattice corneal dystrophy type III-A. Am J Ophthalmol 1999;127:456-8.
35. Klintworth GK, Valnickova Z, Kielar RA, et al. Familial subepithelial corneal amyloidosis - a lactoferrin-related amyloidosis. Invest Ophthalmol Vis Sci 1997;38:2756-63.
36. Klintworth GK, Sommer JR, Obrian G et al. Familial subepithelial corneal amyloidosis (gelatinous drop-like dystrophy): exclusion of linkage to lactoferrin gene. Mol Vis 1998;4:31.
37. Kinoshita S, Yokoi N, Komuro A. Barrier function of ocular surface epithelium. In: Lass J, ed. Advances in corneal research. New York: Plenum Press, 1997:47-55.
38. Quantock AJ, Nishida K, Kinoshita S. Histopathology of recurrent gelatinous-drop-like corneal dystrophy. Cornea 1998;17:215-21.